Measurement system for measuring the concentration of an analyte with a subcutaneous analyte sensor

US10660521B2 · kind B2 · utility

Assignee

• Roche Diabetes Care, Inc. · US

Inventors

• Stefan Riebel · Frankfurt am Main, DE
• Kai-Oliver Schwenker · Haßloch, DE
• Ralf Schmitz · Frankfurt am Main, DE
• Carsten Mueglitz · Sonneberg, DE
• Thomas Eissenloeffel · Heidelberg, DE

Key dates

• Filing date: Jun 3, 2016
• Grant date: May 26, 2020
• Expiry date: May 25, 2037

Classification

• Technology area (CPC G): Physics
• CPC primary: G16H40/67
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

The invention provides for a medical system comprising a control unit and a medical appliance. The medical appliance comprises: a first processor and a monitoring system for measuring an analyte concentration subcutaneously. The control unit comprises a second processor and a second memory with a persistent partition and an application partition containing a medical application and application data comprising a medical data entry. The medical application backs up the application data as archived data in the persistent partition. The first processor is programmed to: record the analyte concentration, generate the medical data entry using the analyte concentration, and transfer the medical data entry to the control unit. The second memory further contains an operating system operable for de-installing the medical application without deleting the archived data.